Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Clin Sci (Lond). 2010 Aug 5;119(10):407–421. doi: 10.1042/CS20100094

Figure 5. ZO-1 immunofluorescence before and after treatment with TGRL lipolysis products.

Figure 5

Images of human aortic endothelial cell monolayers showing (A) continuous ZO-1 staining with treatment with TGRL (150 mg/dl triacylglycerol), and (B) discontinuity and radial rearrangement of ZO-1 (arrow) during exposure to lipolysis products generated from co-incubation of TGRL (150 mg/dl) + LpL (2 units/ml), causing increased endothelial layer permeability. This Figure was reproduced from [166] and is used with permission. Copyright (2007) American Physiological Society.